Wengel Kathryn E has filed 68 insider transactions across 2 companies since February 2023.
Most recent transaction: a option exercise of 606 shares of JOHNSON & JOHNSON ($JNJ) on February 15, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 606 | $0.00 | 114,654.8735 | 2,429,400,000 | 0.53% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 6414 | $244.55 | 114,048.8735 | 2,429,400,000 | 5.32% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 13706 | $0.00 | 120,462.8735 | 2,429,400,000 | 12.84% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 217 | $244.55 | 106,756.8735 | 2,429,400,000 | 0.20% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 651 | $0.00 | 106,973.8735 | 2,429,400,000 | 0.61% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Performance Share Units | 13706 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Restricted Share Units | 1217 | $0.00 | 1,217.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 13, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 651 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Employee Stock Options (Right to Buy) | 16945 | $0.00 | 16,945.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 635 | $0.00 | 1,268.0000 | 2,429,400,000 | 33.37% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 606 | $0.00 | 606.0000 | 2,429,400,000 | 50.00% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 325 | $243.45 | 114,654.8735 | 2,429,400,000 | 0.28% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 635 | $0.00 | 114,979.8735 | 2,429,400,000 | 0.56% | 0.00% |
| Feb. 15, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 310 | $243.45 | 114,344.8735 | 2,429,400,000 | 0.27% | 0.00% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | M | Restricted Stock Unit | 897 | $0.00 | 773.0000 | 83,000,000 | 53.71% | 0.00% |
| Feb. 11, 2026 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | M | Common Stock | 897 | $0.00 | 4,133.0000 | 83,000,000 | 27.72% | 0.00% |
| Feb. 10, 2026 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | A | Restricted Stock Unit | 773 | $0.00 | 1,670.0000 | 83,000,000 | 86.18% | 0.00% |
| Feb. 9, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Performance Share Units | 13706 | $0.00 | 13,706.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 6, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Employee Stock Options (Right to Buy) | 38945 | $101.87 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 27270 | $239.99 | 106,322.8735 | 2,429,400,000 | 20.41% | 0.00% |
| Feb. 6, 2026 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 38945 | $101.87 | 133,592.8735 | 2,429,400,000 | 41.15% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Restricted Share Units | 1903 | $0.00 | 1,903.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Employee Stock Options (Right to Buy) | 30841 | $0.00 | 30,841.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 651 | $0.00 | 651.0000 | 2,429,400,000 | 50.00% | 0.00% |
| Feb. 13, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 651 | $0.00 | 89,958.8735 | 2,429,400,000 | 0.73% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 223 | $155.26 | 89,735.8735 | 2,429,400,000 | 0.25% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 1530 | $0.00 | 91,265.8735 | 2,429,400,000 | 1.71% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 480 | $156.71 | 90,785.8735 | 2,429,400,000 | 0.53% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 607 | $0.00 | 91,392.8735 | 2,429,400,000 | 0.67% | 0.00% |
| Feb. 18, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 200 | $156.15 | 91,192.8735 | 2,429,400,000 | 0.22% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 5837 | $0.00 | 97,029.8735 | 2,429,400,000 | 6.40% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 2393 | $156.71 | 94,636.8735 | 2,429,400,000 | 2.47% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 1530 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 15, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 607 | $0.00 | 1,212.0000 | 2,429,400,000 | 33.37% | 0.00% |
| Feb. 14, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Performance Share Units | 5837 | $0.00 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 11, 2025 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | A | Restricted Stock Unit | 897 | $0.00 | 897.0000 | 83,400,000 | 9999.99% | 0.00% |
| Feb. 10, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Performance Share Units | 5837 | $0.00 | 5,837.0000 | 2,429,400,000 | 9999.99% | 0.00% |
| Feb. 7, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Employee Stock Options (Right to Buy) | 32762 | $100.06 | 0.0000 | 2,429,400,000 | 100.00% | 0.00% |
| Feb. 7, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 32762 | $100.06 | 115,383.8735 | 2,429,400,000 | 39.65% | 0.00% |
| Feb. 7, 2025 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 26076 | $153.12 | 89,307.8735 | 2,429,400,000 | 22.60% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | M | Common Stock | 944 | $0.00 | 3,236.0000 | 83,400,000 | 41.19% | 0.00% |
| Feb. 6, 2025 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | M | Restricted Stock Unit | 944 | $0.00 | 0.0000 | 83,400,000 | 100.00% | 0.00% |
| Feb. 15, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Employee Stock Options (Right to Buy) | 29275 | $0.00 | 29,275.0000 | 2,560,400,000 | 9999.99% | 0.00% |
| Feb. 15, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Restricted Share Units | 1819 | $0.00 | 1,819.0000 | 2,560,400,000 | 9999.99% | 0.00% |
| Feb. 13, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 333 | $157.85 | 82,610.8735 | 2,560,400,000 | 0.40% | 0.00% |
| Feb. 13, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 651 | $0.00 | 82,943.8735 | 2,560,400,000 | 0.79% | 0.00% |
| Feb. 13, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 651 | $0.00 | 1,302.0000 | 2,560,400,000 | 33.33% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 1987 | $0.00 | 89,358.8735 | 2,560,400,000 | 2.27% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Performance Share Units | 11826 | $0.00 | 0.0000 | 2,560,400,000 | 100.00% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 7066 | $157.40 | 82,292.8735 | 2,560,400,000 | 7.91% | 0.00% |
| Feb. 12, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 11826 | $0.00 | 87,371.8735 | 2,560,400,000 | 15.65% | 0.00% |
| Feb. 9, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Employee Stock Options (Right to Buy) | 35638 | $90.44 | 0.0000 | 2,560,400,000 | 100.00% | 0.00% |
| Feb. 9, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 35638 | $90.44 | 102,878.8735 | 2,560,400,000 | 53.00% | 0.00% |
| Feb. 9, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 27333 | $156.76 | 75,545.8735 | 2,560,400,000 | 26.57% | 0.00% |
| Feb. 8, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 1009 | $156.33 | 67,240.8735 | 2,560,400,000 | 1.48% | 0.00% |
| Feb. 8, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 1971 | $0.00 | 68,249.8735 | 2,560,400,000 | 2.97% | 0.00% |
| Feb. 8, 2024 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 1971 | $0.00 | 0.0000 | 2,560,400,000 | 100.00% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | M | Restricted Stock Unit | 947 | $0.00 | 944.0000 | 83,900,000 | 50.08% | 0.00% |
| Feb. 7, 2024 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | M | Common Stock | 947 | $0.00 | 2,292.0000 | 83,900,000 | 70.41% | 0.00% |
| Feb. 6, 2024 | LABCORP HOLDINGS INC. | $LH | Wengel Kathryn E | Director | A | Restricted Stock Unit | 944 | $0.00 | 1,891.0000 | 83,900,000 | 99.68% | 0.00% |
| June 12, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | S | Common Stock | 12465 | $160.00 | 66,273.8735 | 2,663,900,000 | 15.83% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 4891 | $162.01 | 78,733.8735 | 2,663,900,000 | 5.85% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Employee Stock Options (Right to Buy) | 32317 | $0.00 | 32,317.0000 | 2,663,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Common Stock | 10839 | $0.00 | 83,624.8735 | 2,663,900,000 | 14.89% | 0.00% |
| Feb. 13, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | A | Restricted Share Units | 1953 | $0.00 | 1,953.0000 | 2,663,900,000 | 9999.99% | 0.00% |
| Feb. 10, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Common Stock | 1807 | $0.00 | 73,452.8735 | 2,663,900,000 | 2.52% | 0.00% |
| Feb. 10, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | M | Restricted Share Units | 1807 | $0.00 | 0.0000 | 2,663,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | JOHNSON & JOHNSON | $JNJ | Wengel Kathryn E | EVP, Chief TO and Risk Officer | F | Common Stock | 667 | $162.08 | 72,785.8735 | 2,663,900,000 | 0.91% | 0.00% |